INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

50 hedge funds and large institutions have $71.2M invested in Inozyme Pharma in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 9 closing their positions.

Holders
50
Holders Change
-1
Holders Change %
-1.96%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
13
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$2.12M
2
RSCM
2
Rock Springs Capital Management
Maryland
$4.88M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$7.14M
4
BlackRock
4
BlackRock
New York
$3.59M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$49K

Top Sellers

1
O
1
OrbiMed
New York
$0
2
CCM
2
CAAS Capital Management
New York
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$10M 2,444,379 – –
DM
2
Deerfield Management
New York
$9.59M 2,344,786 – –
SI
3
Sofinnova Investments
California
$8.3M 2,028,308 – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$7.14M 1,746,672 +147,644 +9%
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$6.51M 1,591,154 – –
RSCM
6
Rock Springs Capital Management
Maryland
$4.88M 1,193,195 +324,729 +37%
SCM
7
Suvretta Capital Management
New York
$4.14M 1,013,216 – –
CA
8
CHI Advisors
New York
$3.65M 892,057 – –
BlackRock
9
BlackRock
New York
$3.59M 878,400 +41,402 +5%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$2.49M 609,594 +214 +0%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$2.12M 520,763 +395,610 +316%
Vanguard Group
12
Vanguard Group
Pennsylvania
$2M 489,613 +894 +0.2%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$1.27M 310,933 -13,454 -4%
MB
14
MPM BioImpact
Massachusetts
$1.21M 294,980 -7,635 -3%
State Street
15
State Street
Massachusetts
$773K 189,005 +1,903 +1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$760K 186,007 +1,988 +1%
Northern Trust
17
Northern Trust
Illinois
$466K 113,823 -6,939 -6%
BBA
18
Baker Bros. Advisors
New York
$438K 106,999 – –
Citadel Advisors
19
Citadel Advisors
Florida
$402K 98,297 -8,681 -8%
BCM
20
Bridgeway Capital Management
Texas
$235K 57,400 -20,000 -26%
Nuveen Asset Management
21
Nuveen Asset Management
Illinois
$172K 43,574 +1,313 +3%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$164K 40,013 -1,183 -3%
Charles Schwab
23
Charles Schwab
California
$125K 30,497 -5,930 -16%
OMC
24
Overbrook Management Corp
New York
$68K 16,726 – –
Morgan Stanley
25
Morgan Stanley
New York
$64K 15,937 -3,503 -18%
1
2 3